Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,198 | -12,946 | -69,044 | -47,767 | -34,223 |
| Depreciation Amortization | 1,336 | 692 | 2,696 | 2,058 | 1,351 |
| Accounts receivable | -1,545 | -1,361 | -1,039 | -826 | -522 |
| Accounts payable and accrued liabilities | 1,704 | 2,118 | -905 | -60 | 657 |
| Other Working Capital | -4,895 | -3,203 | -6,695 | -5,420 | -3,802 |
| Other Operating Activity | -3,637 | -4,789 | 9,261 | 3,329 | 3,362 |
| Operating Cash Flow | $-36,235 | $-19,489 | $-65,726 | $-48,687 | $-33,177 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,653 | 18,837 | 46,358 | 26,000 | 6,947 |
| PPE Investments | -345 | -140 | -641 | -314 | -206 |
| Purchase Sale Intangibles | -18 | -10 | -260 | -250 | -175 |
| Other Investing Activity | 2,703 | 1,434 | 4,003 | 2,811 | 1,496 |
| Investing Cash Flow | $34,011 | $20,131 | $49,721 | $28,498 | $8,237 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40 | 1 | 35 | 33 | 30 |
| Other Financing Activity | -667 | -344 | -1,334 | -1,016 | -665 |
| Financing Cash Flow | $-627 | $-343 | $-1,300 | $-984 | $-635 |
| Exchange Rate Effect | 1,056 | 885 | -5,683 | -951 | -1,904 |
| Beginning Cash Position | 74,424 | 76,941 | 97,963 | 99,537 | 97,831 |
| End Cash Position | 72,629 | 78,125 | 74,976 | 77,414 | 70,352 |
| Net Cash Flow | $-1,795 | $1,184 | $-22,988 | $-22,123 | $-27,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,235 | -19,489 | -65,726 | -48,687 | -33,177 |
| Capital Expenditure | -345 | -140 | -641 | -314 | -206 |
| Free Cash Flow | -36,580 | -19,628 | -66,366 | -49,000 | -33,383 |